Literature DB >> 7893871

Invasive otitis externa due to Aspergillus species: case report and review.

G Gordon1, N A Giddings.   

Abstract

Aspergillus flavus, an unusual cause of malignant external otitis, was identified in pure culture of tissue from two patients in which histologic examinations demonstrated branching septate hyphae invading the temporal bone. Both patients presented with protracted external ear pain. Multiple attempts at treatment with topical agents (polymyxin B sulfate-neomycin sulfate-hydrocortisone), oral agents (cephalexin and ciprofloxacin), and parenteral agents (ceftazidime and tobramycin) were unsuccessful before definitive diagnosis was made. Treatment with amphotericin B, followed by a more protracted course of itraconazole, resulted in an apparent cure for these patients. Follow-up examination at 15 months after the discontinuation of therapy with itraconazole demonstrated no recurrence of infection. Previously reported cases have predominantly involved immunocompromised persons, and these cases are summarized.

Entities:  

Mesh:

Year:  1994        PMID: 7893871     DOI: 10.1093/clinids/19.5.866

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Treatment of otitis externa in children.

Authors:  I Brook
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

Review 2.  Otogenic skull base osteomyelitis caused by invasive fungal infection. Case report and literature review.

Authors:  Dominik Stodulski; Bozena Kowalska; Czesław Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-09       Impact factor: 2.503

3.  Otomycosis: subdermal growth in calcified mass.

Authors:  Tomoyuki Hoshino; Mariko Matsumoto
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-24       Impact factor: 2.503

Review 4.  Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Brad Moriyama; Nikolaos V Sipsas; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Roberta Prinapori; Saad J Taj-Aldeen; Barry Brause; Olivier Lortholary; Thomas J Walsh
Journal:  J Infect       Date:  2013-12-27       Impact factor: 6.072

5.  Herpes zoster oticus with meningitis masquerading as malignant otitis externa.

Authors:  Harriet A Cunniffe; Nicholas G Cunniffe
Journal:  BMJ Case Rep       Date:  2019-06-07

Review 6.  A review molecular typing methods for Aspergillus flavus isolates.

Authors:  Inès Hadrich; Fattouma Makni; Sourour Neji; Fatma Cheikhrouhou; Hayet Sellami; Ali Ayadi
Journal:  Mycopathologia       Date:  2011-03-03       Impact factor: 2.574

7.  Skull based osteomyelitis due to postsurgery malignant otitis externa presenting as stroke.

Authors:  Nicola Su; Irfan Syed; Richard Garth
Journal:  BMJ Case Rep       Date:  2011-05-24

8.  Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient.

Authors:  Aukje van Tol; Jeroen van Rijswijk
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-04       Impact factor: 2.503

9.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

Review 10.  Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.

Authors:  Perrine Parize; Marie-Olivia Chandesris; Fanny Lanternier; Sylvain Poirée; Jean-Paul Viard; Boris Bienvenu; Michaël Mimoun; Frédéric Méchai; Marie-France Mamzer; Philippe Herman; Marie-Elisabeth Bougnoux; Marc Lecuit; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.